Study S001037

An Open-label，Single-arm，Sequential，Single-center Clinical Trial of the Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection (PEX168) in Healthy Adult Subjects

ClinicalTrials.gov record

Registration

Registration: NCT02451527
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 16
Start: 2015-05
Primary completion: 2015-09
Lead sponsor: First Affiliated Hospital Xi'an Jiaotong University
Conditions: Healthy
Interventions: DRUG:Digoxin; DRUG:PEX168
Results posted: FALSE

Registered primary outcomes

Composite of pharmacokinetic (PK) parameters of digoxin with and without PEX168 in plasma and urine (cmax, t 1/2) [Day 1 through Day 44]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.